Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [A new androgen receptor antagonist : Darolutamide for patients with non-metastatic castration-resistant prostate cancer].

Literature DB >> 31471641

[A new androgen receptor antagonist : Darolutamide for patients with non-metastatic castration-resistant prostate cancer].

C Kesch¹, B A Hadaschik².

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2019 PMID： 31471641 DOI： 10.1007/s00120-019-01036-4

Source DB: PubMed Journal: Urologe A ISSN： 0340-2592 Impact factor: 0.639

Keyword Cloud
References

× No keyword cloud information.

3 in total

1. Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.

Authors: Matthew R Smith; Fred Saad; Simon Chowdhury; Stéphane Oudard; Boris A Hadaschik; Julie N Graff; David Olmos; Paul N Mainwaring; Ji Youl Lee; Hiroji Uemura; Angela Lopez-Gitlitz; Géralyn C Trudel; Byron M Espina; Youyi Shu; Youn C Park; Wayne R Rackoff; Margaret K Yu; Eric J Small
Journal: N Engl J Med Date: 2018-02-08 Impact factor: 91.245

2. Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer.

Authors: Maha Hussain; Karim Fizazi; Fred Saad; Per Rathenborg; Neal Shore; Ubirajara Ferreira; Petro Ivashchenko; Eren Demirhan; Katharina Modelska; Andrew Krivoshik; Cora N Sternberg
Journal: N Engl J Med Date: 2018-06-28 Impact factor: 91.245

3. Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer.

Authors: Wanling Xie; Meredith M Regan; Marc Buyse; Susan Halabi; Philip W Kantoff; Oliver Sartor; Howard Soule; Noel W Clarke; Laurence Collette; James J Dignam; Karim Fizazi; Wendy R Paruleker; Howard M Sandler; Matthew R Sydes; Bertrand Tombal; Scott G Williams; Christopher J Sweeney
Journal: J Clin Oncol Date: 2017-08-10 Impact factor: 44.544

3 in total